• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, September 8, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home Headlines

Previous influenza virus exposures enhance susceptibility in another…

Bioengineer.org by Bioengineer.org
January 31, 2018
in Headlines, Health, Science News
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: McMaster University

Hamilton, ON (January 16, 2018) – While past exposure to influenza A viruses often builds immunity to similar, and sometimes different, strains of the virus, Canadian researchers are calling for more attention to exceptions to that rule.

New data analysis suggests that people born at the time of the 1957 H2N2 or Asian Flu pandemic were at a higher risk of dying during the 2009 H1N1 Swine Flu pandemic as well as the resurgent H1N1 outbreak in 2013-2014. And it is not the first time this has happened.

Results of the study by researchers of McMaster University and the Université de Montréal were published today in mBio, published by the American Society for Microbiology.

"Reported situations in which previous influenza virus exposures have enhanced susceptibility are rare and poorly understood," said Matthew Miller, senior author of the paper, an assistant professor of biochemistry and biomedical sciences at McMaster University, and senior researcher with its Michael G. DeGroote Institute of Infectious Disease Research.

"This study's results have important implications for pandemic risk assessment and should inform laboratory studies aimed at uncovering what's responsible for this effect."

The influenza A virus continues to pose one of the most pressing threats to global public health due to its tendency to cause a pandemic. Over the last 100 years alone, at least five such pandemics have occurred, including the 1918 H1N1 Spanish Flu, the 1957 H2N2 Asian Flu, the 1968 H3N2 "Hong Kong Flu", the 1977 Russian Flu and the 2009 H1N1 Swine Flu.

Miller and the teams from both universities reviewed monthly mortality and influenza circulation data from October 1997 to July 2014 in the United States and Mexico. They identified peaks in excess mortality during the 2009 H1N1 Swine Flu pandemic and during the resurgent 2013-2014 H1N1 outbreak among people born in 1952.

The results align with at least two previous influenza A virus pandemics, in 1918 and 1968, when there were higher death rates among those born during previous pandemic years in 1890 and 1918, respectively.

"We suggest the phenomenon of 1918 is not unique," Miller said. "We believe that exposure to pandemic influenza early in life is a risk factor for mortality during subsequent cross-strain pandemics."

Miller suggested further research is needed so appropriate vaccines may be developed.

"We believe there is an important piece missing in this puzzle that has been overlooked in most investigations on pandemic influenza," he said.

"Our research highlights the urgent need to develop more broadly-protective 'universal' influenza virus vaccines – capable of providing protection against both seasonal and pandemic influenza strains."

###

The study was supported in part by funding from the Canadian Institutes of Health Research.

Editors: A photo of Matthew Miller is attached.

For more information:
Veronica McGuire
Media Relations
Faculty of Health Sciences
McMaster University
[email protected]
905-525-9140, ext. 22169

Media Contact

Veronica McGuire
[email protected]
905-525-9140 x22169
@mcmasteru

Home

Share12Tweet7Share2ShareShareShare1

Related Posts

Tarlatamab Combined with Anti-PD-L1 Shows Promising Safety and Unprecedented Overall Survival as First-Line Maintenance Therapy Following Chemo-Immunotherapy in ES-SCLC

September 8, 2025
Quorum Quenching Beta-Lactamase from Chromohalobacter Sp.

Quorum Quenching Beta-Lactamase from Chromohalobacter Sp.

September 8, 2025

X-ray Insights on Elodontomas in South African Rodents

September 8, 2025

New Clinical Study Advances Understanding of Mesothelioma and Unveils Potential Treatment Pathways

September 8, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    150 shares
    Share 60 Tweet 38
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    116 shares
    Share 46 Tweet 29
  • First Confirmed Human Mpox Clade Ib Case China

    56 shares
    Share 22 Tweet 14
  • A Laser-Free Alternative to LASIK: Exploring New Vision Correction Methods

    47 shares
    Share 19 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Tarlatamab Combined with Anti-PD-L1 Shows Promising Safety and Unprecedented Overall Survival as First-Line Maintenance Therapy Following Chemo-Immunotherapy in ES-SCLC

Quorum Quenching Beta-Lactamase from Chromohalobacter Sp.

X-ray Insights on Elodontomas in South African Rodents

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.